pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-325 |
Genomic Coordinates | chrX: 105379082 - 105379179 |
Synonyms | Mirn325, mmu-mir-325, Mir325 |
Description | Mus musculus miR-325 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-325-3p |
Sequence | 54| UUUAUUGAGCACCUCCUAUCAA |75 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Hlf | ||||||||||||||||||||
Synonyms | E230015K02Rik | ||||||||||||||||||||
Description | hepatic leukemia factor | ||||||||||||||||||||
Transcript | NM_172563 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Hlf | |||||||||||||||||||||
3'UTR of Hlf (miRNA target sites are highlighted) |
>Hlf|NM_172563|3'UTR 1 GATGGCATTTTTGTGGGCTGGCTTTTGAATAGATGGACAGCTTGTTTCCTGTCTGGTAGCCCCACACCCAAACCAACCTT 81 TCTGACATCAGCACTTTACCAGAGGCATAAACGCAACTGACTCATATTTTGGTGTGCATCTATGCGTATGTATGTATGTT 161 TGTGTGTGTGTATATGTGCTTATGGTCCCATGTGTGGTCAGCGGTGTGCATGTGTGAGCGTGTATATGTGTGTATTCCTT 241 CACACTTGTCGTTTAAAGATAGTCCTCTTGTTGTCTTTTAGTTCCAAACAAGAAAGGTGCCATGTTTTTTATTCCACCCT 321 GGAGACTCCCATGGGGTTTCCTCCCCTTCCTTCTCCCTTCCTGCCCCTTTCTGCCTTGCTCTGTGTTCTAGCGATCTCAC 401 TTGGCCAGGGTCTGTGTTGCTTCAGGAAGCAGGGCCCTGGATCTCAGTGATCAAGACCATAAGCTCTTGTTTCTGTTTCA 481 GCCATGAATTACCATGCTGGAAAGGTGCATAGCATACCCTAGCACTGCGCGCAGCTGAATTCCTTCATAGGTTGCCCCAC 561 TTCCCTTCCCTTTTTCCTCCCCACCCTTTCTCGTTTTTTCCTTTCAGTTTTGGTGACACTTGTCTTCAAATTTAAAGTGC 641 TGTTTAGATTTAGTAGAGTCCCATATTTACTTACTGCTACCTACTAAGTTTCCTTTTAATTCCACCAACCCCAGATAAGT 721 AAGTACCATTCCTTATAGAACACAGAGTGTGTTTTGCACTGTCTGTACCTAAAGCAATAATCCTAGTGTACGCTAGAGCA 801 TGCTGCCTGAGTATTAACTAGTGGACGTAGGAAAAAAAATTCCCTACCTAGGAATTTCACTGTCTTTTAAAAAAAAAACT 881 CAAAAATCAAGTAATGCATTTGTGCATGACCAGAATATTCTCAGGACAGGGAAGCAGAGGGCAAGGGAAGGCCTAAGAAT 961 GAGGGGTTAATTTATCAGTATGTATGCCAAAAACATAATAATAATGCATCTTGGAGAAGCCTTTGCCACGGTGTGCTTCG 1041 TCGTGCGTCTCCCCTTCCCACACCCAGCCCATTCCCACTTTTCTAGCCCATTCACTTTCTCCATTTCCCTCTTGATATTC 1121 AAAACGATTGACTTAAGATTCAGTTTACCCACTTTGTTTTATAATATATATATTTGGGGGGGGGACGATATTTTGCTGTT 1201 TTTAGAAATCAGTTAATTAAGTGAAAAAGTTGATGTTTTGAAAAGCCCTCCCTTGACCCCCACCCCCACCCCCCGTGGTG 1281 TCCTTTTGAATGCCTCACAAATGAATGATTCCGGAGCCCGTGTTTCTCATCCTCTGTTTGCTTTTGAACATATGTGCGCC 1361 TATCAAGTGGACTTCTGAAAAAAAAAATGAATGTAAAAGACACTGGTGTATCTCAGAATGGGATGGTGTTGTCACAAACT 1441 GTGGTTTCTCCGATCAATTTAAATGTTTACTATAGACCAAAAGGAGAGATTATTAAATCGTTTAATGTTTATACAGAGTA 1521 ATTATAGGAAGTTCTTTTTTTGTACAGTATTTTTCAGATATAAATACTGACAATGTATTTTGGAAGACATATATTATATA 1601 TAGAAAAGAGAAAAAAAGGAAAACTATTCCGTGTTTTAAAATTATATAGCAAAGATATATATTCACCAATGCTGTTCAGA 1681 GGAGTGCTTGGGGGCTTTTGAAATCTTTAATATTTTAAACCTATTACTGACACATCAGCATGTTTTCTGCTTAAAATTAA 1761 AATTTTATGACAATACTGAGGCTTGCTGTGACGACTCCTGCTCCAACGCTTTCTTGTTTCTTATTAGGTCTCAGAAGGAA 1841 GTCAGTTAACGTCACCCAAAAGCACAAAACGGGTTTTAGTCAAATATTTATTGGATGATCCAGTGTTTTTTAGGAAAAGC 1921 ATCTGCCACATAAATGTTCACTTCAGGATTCTGAGTCGTTGGAATGGAGTATGGCTGCCAGAGCCCCAGATGATTTTGTT 2001 CGCTTTCGGCCTGTGTATCTATCTCACGCAGTGTAAGGTTGACCTCGGTGCTATGTGTACGGCTTAGAGTTTGATAGCTG 2081 TTTTGACTTTAAAGATGGCTGTTATTTTGTTTCACTGAGTTGTATAATGTCAAGAGAGTCTGCTGTTTCTTCAAAAGCAC 2161 ATTTTTGTGCTCGATTAAAATCCCCTTCCATCCATGGATGTTTTCCGGTCTCCTGCCTCCACAGTATCTGACTTCTCTGC 2241 GGATCCAGTGATGCCCTCCCCCCTCCCTCAGCCACTCCGCTGTCCAGTGTCACAGATCTGGAAAACGAGACCTGTAGGTT 2321 TCTTCCCAGGTTCCTGTTGTATTCCACGGTGAGAGATGAGAGAGTGAGAGAAATAAAATACATTTTGCAAGCAAATTACT 2401 GATTAAAAAAAATGTTTCAACCATGTTGTATAGAACTGAATAAGAGATAATTCAGTAATAGCCATGGGACACCAAAAAGT 2481 TGGTCCTTTTGAAGATAGAGAAAGAGAGGGATTGCAGAACTGTTCAATGACAGTGCTTGCCAGGGCACAGATGAGTACTT 2561 AAGGAGAGAAGTGTTCAAGGGTTGCACTGTGGCCCACCCAGACACATGGAACCATCCAGTACTCGATGAAGAAAAGCATG 2641 CCTGGCCTTTCTTGGAATTGTTTTTACCAAATAAACATCACAAATGTTTTCTGCAGAAGATATAAAAAGATCATAATAAA 2721 ACTTATTCTTTTGTATACCAGGAAAGGTTTGTAGAAAACCTACCTCATTCAAAACAAAACAAAACAAAAAACTCAAGAGT 2801 TTGGAATCTCCACAGGTGCCTTATCTGTAGGTAATTATCAGTCCCCCACCCCCAGGCTGACTTCTCTTTGCCCCTGGATA 2881 TTAACTAGATGAGAAAATGCCATTCAATGCCCTGAGAAGCTAGAACCTAGGGTCAGATAACTGCAGCAGACCATAGCCAT 2961 TAGGAAGTCCCATTGTCAACTGTCACCATTTCAAGGTAGGCATCTTTCCATGGTTAATTATTTGGTCATTCCAAATGCAT 3041 CTGAAATGTTGCATGCCCTGCCATTCAGATGCAAAGCACTTCCTGGTCAGGTCATATCTTTTCATTAGTCACATGGATTC 3121 TCGAAGAAAGTTTTAAAAAAAAAAGGAATCAGGGTTTCTCTCTGCTGATGCTCCCCTGAGGGGATGGGGGGGCTTTGGAT 3201 GACAGTCCCCAACTATAGAGGGACTGGTGCTTTGGGTCATTCACAAACCACATCAGGCATGACTTGGCCAGGCCTTTGTC 3281 TCTAAATAGAACAGGCCTTGAAGGGACCATCCTTTGTAGAAGAAGAAGAATGGGCCTATGTTTGAGAATAGCATGATGGG 3361 ACTCAGTCACTGGGTGAGGGGGAAACCAGATAAAAGAACCCAGAGGCTCTTTCTAACCCATTATCTTACCGTGGGAATTT 3441 ACACTGAGTCTAAACATACCTTCGAAAGGGCTACAGCCTCAGGTCTGGATGACCTGCCGTGAGTTGTAAGTGGCAATGTC 3521 TCTCCTGTCCAGGGATGAAACAACTGATGATGTGTAAAATACAAGGAATACTTTGCTCTTTCTAAAAGTTTGTTCAGTTT 3601 GGCCCTTAGCATTCCTTTAGAAAAAACTCAAAACTTCCTCAGAGTTAATTAGTGAGATCCTCAGGCATCGATGCCTGTGG 3681 ATCTCAGACAGCTCTGTGTGTGGCTTGTCCCCACCGGCTGGGATTGGCTTCCTGCAGCTGACTAGGCTGAGGTGTGATGC 3761 CCTCCCTCCCTGGGTACATACCTTCTTCTCTGGCTCTGATTGCACTTGCTTCCTACTGAGGGCTCCTGAGTACAACCCTC 3841 TGGGGAAGCCAAATTCAACTCCAGGTGTTCGGTAAAAATCAGTGTCAATAATAAATGAACAAAACTTGTAGGTCTTGATG 3921 GACTGAATTTTCAATAACTACTGTTAATGCATTTTTGCCAAAATCTGTGTTGGGGAATGTGTGTTTGTGTGTGGATGTTT 4001 AAGTGGAGACAGAAAATCTGTAATTTTTTTTTTAGCACCTCACCAGACATAACAATTAGGTATTATCCTTTCGACAACAC 4081 CACAAAGATTGCATCTGTCAAACAGGCTCAAGTTAACAAGAGGTTAGTGTAATTGTATACCATGATATTGCTGGTATTTA 4161 TGCTGTCAAGTCCAAAACTTCATTTGTTCTTCTAAATGTTTAATAAACTAATTTTTTTCCTTTT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | CD4+ T cells (C57BL/6) |
Disease | MIMAT0004640 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"HITS-CLIP data was present in GSM1013588. RNA binding protein: AGO2. Condition:CD4+ T cells
... - Loeb GB; Khan AA; Canner D; Hiatt JB; et al., 2012, Molecular cell. |
Article |
- Loeb GB; Khan AA; Canner D; Hiatt JB; et al. - Molecular cell, 2012
MicroRNAs (miRNAs) are essential components of gene regulation, but identification of miRNA targets remains a major challenge. Most target prediction and discovery relies on perfect complementarity of the miRNA seed to the 3' untranslated region (UTR). However, it is unclear to what extent miRNAs target sites without seed matches. Here, we performed a transcriptome-wide identification of the endogenous targets of a single miRNA-miR-155-in a genetically controlled manner. We found that approximately 40% of miR-155-dependent Argonaute binding occurs at sites without perfect seed matches. The majority of these noncanonical sites feature extensive complementarity to the miRNA seed with one mismatch. These noncanonical sites confer regulation of gene expression, albeit less potently than canonical sites. Thus, noncanonical miRNA binding sites are widespread, often contain seed-like motifs, and can regulate gene expression, generating a continuum of targeting and regulation.
LinkOut: [PMID: 23142080]
|
27 mmu-miR-325-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT054600 | Arc | activity regulated cytoskeletal-associated protein | 3 | 1 | ||||||||
MIRT577829 | Rinl | Ras and Rab interactor-like | 1 | 1 | ||||||||
MIRT577905 | Prr11 | proline rich 11 | 1 | 1 | ||||||||
MIRT578380 | Krtap6-1 | keratin associated protein 6-1 | 1 | 1 | ||||||||
MIRT578550 | Hsd17b1 | hydroxysteroid (17-beta) dehydrogenase 1 | 1 | 1 | ||||||||
MIRT578770 | Gemin8 | gem nuclear organelle associated protein 8 | 1 | 1 | ||||||||
MIRT580288 | Trhr | thyrotropin releasing hormone receptor | 1 | 1 | ||||||||
MIRT581518 | Ptprd | protein tyrosine phosphatase, receptor type, D | 1 | 1 | ||||||||
MIRT582779 | Kif1c | kinesin family member 1C | 1 | 1 | ||||||||
MIRT585752 | Stard6 | StAR-related lipid transfer (START) domain containing 6 | 1 | 1 | ||||||||
MIRT587310 | Ephx3 | epoxide hydrolase 3 | 1 | 4 | ||||||||
MIRT588735 | Taok3 | TAO kinase 3 | 1 | 1 | ||||||||
MIRT592550 | Mup7 | major urinary protein 7 | 1 | 1 | ||||||||
MIRT592592 | Mup13 | major urinary protein 13 | 1 | 1 | ||||||||
MIRT594207 | Wdr12 | WD repeat domain 12 | 1 | 1 | ||||||||
MIRT594462 | Epyc | epiphycan | 1 | 1 | ||||||||
MIRT594693 | Atp11b | ATPase, class VI, type 11B | 1 | 1 | ||||||||
MIRT594929 | Gjb2 | gap junction protein, beta 2 | 1 | 1 | ||||||||
MIRT594934 | Frem3 | Fras1 related extracellular matrix protein 3 | 1 | 1 | ||||||||
MIRT595784 | Hlf | hepatic leukemia factor | 1 | 1 | ||||||||
MIRT595846 | Set | SET nuclear oncogene | 1 | 1 | ||||||||
MIRT595897 | Cd69 | CD69 antigen | 1 | 1 | ||||||||
MIRT603010 | Klk8 | kallikrein related-peptidase 8 | 1 | 1 | ||||||||
MIRT603579 | Ppm1k | protein phosphatase 1K (PP2C domain containing) | 1 | 1 | ||||||||
MIRT604052 | Esf1 | ESF1 nucleolar pre-rRNA processing protein homolog | 1 | 1 | ||||||||
MIRT736870 | GHRHR | growth hormone releasing hormone receptor | 2 | 0 | ||||||||
MIRT756335 | Gsdmd | gasdermin D | 3 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|